79 related articles for article (PubMed ID: 34120268)
1. Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.
Hanna A; Kim-Kiselak C; Tang R; Metz DC; Yang Z; DeMatteo R; Fraker DL; Roses RE
Ann Surg Oncol; 2021 Dec; 28(13):8838-8846. PubMed ID: 34120268
[TBL] [Abstract][Full Text] [Related]
2. The Morphologic Spectrum of Gastric Type 1 Enterochromaffin-Like Cell Neuroendocrine Tumors.
Poveda JC; Chahar S; Garcia-Buitrago MT; Montgomery EA; McDonald OG
Mod Pathol; 2023 Apr; 36(4):100098. PubMed ID: 36913909
[TBL] [Abstract][Full Text] [Related]
3. Surgical indication of type I gastric neuroendocrine tumors.
Ruiz Pardo J; Sánchez Fuentes PA; Vidaña Márquez E; García-Redondo M; González Sánchez D; Belda Lozano R; Ferrer-Márquez M; Reina Duarte Á
Rev Esp Enferm Dig; 2024 May; 116(5):280-282. PubMed ID: 37170558
[TBL] [Abstract][Full Text] [Related]
4. Gastric Neuroendocrine Tumor Treatment and Survival Outcome Depends on Facility Type.
Platoff RM; Lou J; Bush K; Zhu C; Spitz E; Gaughan JP; Atabek U; Spitz F; Hong YK
Am Surg; 2023 Nov; 89(11):4334-4343. PubMed ID: 35722860
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study.
Nam K; Nam SY; Park JC; Cho YS; Choi HS; Jung K; Park SY; Cho JH; Chun H;
Dig Liver Dis; 2024 Feb; ():. PubMed ID: 38369411
[TBL] [Abstract][Full Text] [Related]
6. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms.
Han D; Li YL; Zhou ZW; Yin F; Chen J; Liu F; Shi YF; Wang W; Zhang Y; Yu XJ; Xu JM; Yang RX; Tian C; Luo J; Tan HY
World J Gastroenterol; 2021 Jun; 27(21):2895-2909. PubMed ID: 34135560
[TBL] [Abstract][Full Text] [Related]
8. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC; Piazuelo MB; Kuipers EJ; Li D
Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
[TBL] [Abstract][Full Text] [Related]
9. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.
Soczomski P; Jurecka-Lubieniecka B; Krzywon A; Cortez AJ; Zgliczynski S; Rogozik N; Oczko-Wojciechowska M; Pawlaczek A; Bednarczuk T; Jarzab B
Front Endocrinol (Lausanne); 2021; 12():681013. PubMed ID: 34122352
[TBL] [Abstract][Full Text] [Related]
10. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
11. Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management.
Dell'Unto E; Esposito G; Rinzivillo M; Marasco M; Annibale B; Panzuto F
Front Med (Lausanne); 2024; 11():1327864. PubMed ID: 38357651
[TBL] [Abstract][Full Text] [Related]
12. ASO Author Reflections: Simplifying the Fundamentals of Gastric Neuroendocrine Tumor Management.
Sok C; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1519-1520. PubMed ID: 38123732
[No Abstract] [Full Text] [Related]
13. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract][Full Text] [Related]
14. Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms.
Guo X; Zhao X; Huang G; Yu Y
Dig Dis Sci; 2024 Jan; 69(1):27-35. PubMed ID: 37971578
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
Cavalcoli F; Gallo C; Coltro LA; Rausa E; Cantù P; Invernizzi P; Massironi S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893475
[No Abstract] [Full Text] [Related]
16. Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm.
Yang ZH; Han YJ; Cheng M; Wang R; Li J; Zhao HP; Gao JB
Front Oncol; 2023; 13():1143291. PubMed ID: 37409252
[TBL] [Abstract][Full Text] [Related]
17. Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs.
Laffi A; Lania AGA; Ragni A; Di Vito V; Liccardi A; Rubino M; Sesti F; Colao A; Faggiano A; On Behalf Of The Nike Group
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190131
[TBL] [Abstract][Full Text] [Related]
18. Current status of the role of endoscopy in evaluation and management of gastrointestinal and pancreatic neuroendocrine tumors.
Nabi Z; Lakhtakia S; Reddy DN
Indian J Gastroenterol; 2023 Apr; 42(2):158-172. PubMed ID: 37129761
[TBL] [Abstract][Full Text] [Related]
19. Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study.
Sheikh-Ahmad M; Saiegh L; Shalata A; Bejar J; Kreizman-Shefer H; Sirhan MF; Matter I; Swaid F; Laniado M; Mubariki N; Rainis T; Rosenblatt I; Yovanovich E; Agbarya A
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
